Concert Pharmaceutic (CNCE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 12-2015 | 12-2014 | 12-2013 | 12-2012 | |
| Sales | 174 | 66,729 | 8,576 | 25,408 | 12,849 |
| Gross Profit | 174 | 66,729 | 8,576 | 25,408 | 12,849 |
| Operating Expenses | 51,341 | 41,941 | 39,174 | 29,818 | 31,459 |
| Operating Income | -51,167 | 24,788 | -30,598 | -4,410 | -18,610 |
| Interest Expense | 0 | 309 | 1,150 | 1,667 | 1,856 |
| Other Income | 447 | 124 | 49 | 21 | 22 |
| Pre-tax Income | -50,720 | 24,603 | -31,699 | -6,056 | -20,444 |
| Income Tax | N/A | 429 | N/A | N/A | N/A |
| Net Income Continuous | -50,720 | 24,174 | -31,699 | -6,056 | -20,444 |
| Net Income | $-50,720 | $24,174 | $-31,699 | $-6,056 | $-20,444 |
| EPS Basic Total Ops | -2.28 | 1.14 | -2.00 | -4.99 | -16.15 |
| EPS Basic Continuous Ops | -2.28 | 1.14 | -2.00 | -4.69 | -15.85 |
| EPS Diluted Total Ops | -2.28 | 1.09 | -2.00 | -4.99 | -16.15 |
| EPS Diluted Continuous Ops | -2.28 | 1.09 | -2.00 | -4.69 | -15.85 |
| EPS Diluted Before Non-Recurring Items | -2.28 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-50,085 | $26,083 | $-28,944 | $-3,140 | $-17,171 |